Literature DB >> 10761457

Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.

M Pirisi1, C A Scott, C Avellini, P Toniutto, C Fabris, G Soardo, C A Beltrami, E Bartoli.   

Abstract

Histologically detectable iron (HDI) and HFE mutations were searched for in liver biopsy specimens from 58 Italian patients with chronic hepatitis C, and morphologic features were compared to examine their reciprocal relation and their contribution to disease progression. HDI was evident in 48% of cases with features of nonhemochromatosis iron overload. Total, sinusoidal, and portal HDI increased with stage; grade was related to all iron scores because of the contribution of portal inflammation and interface hepatitis. HFE mutations were seen in 47% of patients with chronic hepatitis C and in 28% of control subjects; they were related to stage and the His63Asp mutation to portal HDI. On multivariate analysis, grade but not stage or HFE mutations was associated with HDI in all sites. Interface hepatitis with its sequelae (sinusoidal capillarization and microshunting) represents a major factor in iron deposition in chronic hepatitis C and justifies the features of HDI. HFE mutations are not responsible for HDI deposition but could favor the progression of virus-induced damage independently from interference with iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761457     DOI: 10.1309/TRB1-JXUJ-L9R6-9NHX

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C.

Authors:  D Thorburn; G Curry; R Spooner; E Spence; K Oien; D Halls; R Fox; E A B McCruden; R N M MacSween; P R Mills
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 2.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

Review 3.  The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Authors:  Leslie Price; Kris V Kowdley
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

4.  The effect of iron depletion on chronic hepatitis C virus infection.

Authors:  Massimo Franchini; Giovanni Targher; Franco Capra; Martina Montagnana; Giuseppe Lippi
Journal:  Hepatol Int       Date:  2008-05-08       Impact factor: 6.047

Review 5.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

6.  Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C.

Authors:  Hironori Mitsuyoshi; Kohichiroh Yasui; Kanji Yamaguchi; Masahito Minami; Takeshi Okanoue; Yoshito Itoh
Journal:  Int J Hepatol       Date:  2013-04-04

7.  Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis.

Authors:  Francesco Paparo; Giovanni Cenderello; Matteo Revelli; Lorenzo Bacigalupo; Mariangela Rutigliani; Daniele Zefiro; Luca Cevasco; Maria Amico; Roberto Bandelloni; Giovanni Cassola; Gian Luca Forni; Gian Andrea Rollandi
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

8.  Development of a mouse iron overload-induced liver injury model and evaluation of the beneficial effects of placenta extract on iron metabolism.

Authors:  Akihiro Yamauchi; Akiko Kamiyoshi; Takayuki Sakurai; Hiroyuki Miyazaki; Eiichi Hirano; Hong-Seok Lim; Taiichi Kaku; Takayuki Shindo
Journal:  Heliyon       Date:  2019-05-10

9.  Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study.

Authors:  Sina Gerayli; Alireza Pasdar; Mohammad Taghi Shakeri; Samaneh Sepahi; Seyed Mousalreza Hoseini; Mitra Ahadi; Sina Rostami; Zahra Meshkat
Journal:  Iran Red Crescent Med J       Date:  2016-05-15       Impact factor: 0.611

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.